Headquartered in Charlotte, NC, Alveolus is a leading developer of next generation non-vascular interventional stent technology. Alveolus' advanced stenting technology enhances the quality of life for patients who suffer from pulmonary or gastrointestinal obstruction. The Alveolus product ideation process, guided by world leading interventionalists, allows for rapid prototyping and development of products to address the specific requirements for each area of the body. Products are created by physicians, for physicians, with an end goal of enhancing the quality of life and reducing the long term medical costs for patients and their families.
Looking for a particular Alveolus employee's phone or email?
The Alveolus annual revenue was $13.3 million in 2026.
4 people are employed at Alveolus.
Alveolus is based in Charlotte, North Carolina.
The NAICS codes for Alveolus are [621, 62].
The SIC codes for Alveolus are [801, 38, 80, 384].